Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-transretinoic acid plus chemotherapy or with all-transretinoic acid plus arsenic trioxide-Reference-Cited by-同舟云学术

Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-transretinoic acid plus chemotherapy or with all-transretinoic acid plus arsenic trioxide

Published:2014-11-03 Issue:5 Volume:56 Page:1342-1345
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Eghtedar Alireza,Rodriguez Ildefonso,Kantarjian Hagop,O'Brien Susan,Daver Naval,Garcia-Manero Guillermo,Ferrajoli Alessandra,Kadia Tapan,Pierce Sherry,Cortes Jorge,Ravandi Farhad

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.953143

Reference25 articles.

1. The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation

2. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002

3. Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC Trial

4. A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

5. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy;Hematology, Transfusion and Cell Therapy;2024-05

2. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience;Annals of Hematology;2023-12-19

3. Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event‐free survival;Cancer Medicine;2023-08-16

4. BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report;Frontiers in Pharmacology;2023-06-16

5. Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report;Cancer Reports;2022-09-26